肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

我国成人血液透析患者康复治疗的专家共识

2021-11-12 中国康复医学会肾脏病康复专业委员会 中国血液净化 发表于上海

血液透析

维持性血液透析患者功能下降及康复治疗的必要性随着血液透析(hemodialysis,HD)治疗技术的不断进步,维持性血液透析患者的生存期明显延长。

中文标题：

我国成人血液透析患者康复治疗的专家共识

发布机构：

中国康复医学会肾脏病康复专业委员会

发布日期：

2021-11-12

简要介绍：

维持性血液透析患者功能下降及康复治疗的必要性随着血液透析(hemodialysis,HD)治疗技术的不断进步,维持性血液透析(maintenance hemodialysis,MHD)患者的生存期明显延长。本共识围绕肾脏病康复(renal rehabilitation,RR)背景、目的、意义、实施前的评估以及策略等内容，结合国内外循证医学证据、专家共识和指南证据，经过国内权威专家的2轮共同讨论后形成，旨在最大限度提高HDC工作人员对RRP的理论知识、操作技能和参与兴趣，制定适合MHD患者的个体化康复目标

相关资料下载：
[AttachmentFileName(sort=1, fileName=我国成人血液透析患者康复治疗的专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1984f1c00231384c, title=我国成人血液透析患者康复治疗的专家共识, enTitle=, guiderFrom=中国血液净化, authorId=0, author=, summary=维持性血液透析患者功能下降及康复治疗的必要性随着血液透析(hemodialysis,HD)治疗技术的不断进步,维持性血液透析患者的生存期明显延长。, cover=https://img.medsci.cn/202216/1641448463561_5579292.jpg, journalId=0, articlesId=null, associationId=2280, associationName=中国康复医学会肾脏病康复专业委员会, associationIntro=中国康复医学会肾脏病康复专业委员会, copyright=0, guiderPublishedTime=Fri Nov 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">维持性血液透析患者功能下降及康复治疗的必要性随着血液透析(hemodialysis,HD)治疗技术的不断进步,维持性血液透析(maintenance hemodialysis,MHD)患者的生存期明显延长。本共识围绕肾脏病康复(renal rehabilitation,RR)背景、目的、意义、实施前的评估以及策略等内容，结合国内外循证医学证据、专家共识和指南证据，经过国内权威专家的2轮共同讨论后形成，旨在最大限度提高HDC工作人员对RRP的理论知识、操作技能和参与兴趣，制定适合MHD患者的个体化康复目标</span></p>, tagList=[TagDto(tagId=2080, tagName=血液透析)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=95, categoryName=康复医学, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2080, guiderKeyword=血液透析, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5712, appHits=306, showAppHits=0, pcHits=553, showPcHits=5400, likes=2, shares=28, comments=15, approvalStatus=1, publishedTime=Thu Jan 06 13:49:05 CST 2022, publishedTimeString=2021-11-12, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Jan 06 13:50:49 CST 2022, updatedBy=6459136, updatedName=玉在山, updatedTime=Sat Jan 06 06:17:38 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=我国成人血液透析患者康复治疗的专家共识.pdf)])
我国成人血液透析患者康复治疗的专家共识.pdf
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1242172, encodeId=9ba212421e28e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39c15502481, createdName=ms6000000255620679, createdTime=Tue Aug 30 22:41:34 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237500, encodeId=d572123e5003e, content=对我很有帮助！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dba8267459, createdName=凌晨时光, createdTime=Tue Aug 09 08:46:45 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235262, encodeId=bf4a123526278, content=很有帮助～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f68252553, createdName=ms1000000355867689, createdTime=Thu Jul 28 12:26:46 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228972, encodeId=1dbe12289e2a8, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25748049, createdName=ms5000000726634951, createdTime=Mon Jun 27 16:11:01 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217019, encodeId=c9ae121e019b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aaa35157257, createdName=江南小护士, createdTime=Thu May 05 11:30:57 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-08-30 ms6000000255620679

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1242172, encodeId=9ba212421e28e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39c15502481, createdName=ms6000000255620679, createdTime=Tue Aug 30 22:41:34 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237500, encodeId=d572123e5003e, content=对我很有帮助！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dba8267459, createdName=凌晨时光, createdTime=Tue Aug 09 08:46:45 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235262, encodeId=bf4a123526278, content=很有帮助～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f68252553, createdName=ms1000000355867689, createdTime=Thu Jul 28 12:26:46 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228972, encodeId=1dbe12289e2a8, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25748049, createdName=ms5000000726634951, createdTime=Mon Jun 27 16:11:01 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217019, encodeId=c9ae121e019b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aaa35157257, createdName=江南小护士, createdTime=Thu May 05 11:30:57 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-08-09 凌晨时光

    对我很有帮助！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1242172, encodeId=9ba212421e28e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39c15502481, createdName=ms6000000255620679, createdTime=Tue Aug 30 22:41:34 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237500, encodeId=d572123e5003e, content=对我很有帮助！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dba8267459, createdName=凌晨时光, createdTime=Tue Aug 09 08:46:45 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235262, encodeId=bf4a123526278, content=很有帮助～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f68252553, createdName=ms1000000355867689, createdTime=Thu Jul 28 12:26:46 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228972, encodeId=1dbe12289e2a8, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25748049, createdName=ms5000000726634951, createdTime=Mon Jun 27 16:11:01 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217019, encodeId=c9ae121e019b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aaa35157257, createdName=江南小护士, createdTime=Thu May 05 11:30:57 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-07-28 ms1000000355867689

    很有帮助～

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1242172, encodeId=9ba212421e28e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39c15502481, createdName=ms6000000255620679, createdTime=Tue Aug 30 22:41:34 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237500, encodeId=d572123e5003e, content=对我很有帮助！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dba8267459, createdName=凌晨时光, createdTime=Tue Aug 09 08:46:45 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235262, encodeId=bf4a123526278, content=很有帮助～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f68252553, createdName=ms1000000355867689, createdTime=Thu Jul 28 12:26:46 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228972, encodeId=1dbe12289e2a8, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25748049, createdName=ms5000000726634951, createdTime=Mon Jun 27 16:11:01 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217019, encodeId=c9ae121e019b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aaa35157257, createdName=江南小护士, createdTime=Thu May 05 11:30:57 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-06-27 ms5000000726634951

    实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1242172, encodeId=9ba212421e28e, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39c15502481, createdName=ms6000000255620679, createdTime=Tue Aug 30 22:41:34 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237500, encodeId=d572123e5003e, content=对我很有帮助！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dba8267459, createdName=凌晨时光, createdTime=Tue Aug 09 08:46:45 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235262, encodeId=bf4a123526278, content=很有帮助～, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76f68252553, createdName=ms1000000355867689, createdTime=Thu Jul 28 12:26:46 CST 2022, time=2022-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228972, encodeId=1dbe12289e2a8, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25748049, createdName=ms5000000726634951, createdTime=Mon Jun 27 16:11:01 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217019, encodeId=c9ae121e019b7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aaa35157257, createdName=江南小护士, createdTime=Thu May 05 11:30:57 CST 2022, time=2022-05-05, status=1, ipAttribution=)]
    2022-05-05 江南小护士

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2021 KSN临床实践指南：最佳血液透析治疗

韩国肾脏病学会(KSN,Korean Society of Nephrology) · 2021-12-04

血液净化标准操作规程（2021版）

中华人民共和国国家卫生健康委员会 · 2021-11-09

血液灌流在维持性血液透析患者中的临床应用上海专家共识

上海市医学会(ShangHai Medical Association) · 2021-09-30

2019 ERBP临床实践指南：成人血液透析患者动静脉瘘和移植物围术期和术后护理

欧洲肾脏最佳临床实践(ERBP,European Renal Best Practice) · 2019-06-01

2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2019-05-31

2019 香港肾脏服务临床实践指南：血液透析

香港医学相关专家组（统称） · 2019-03-02

拓展阅读

血液透析室建设与管理指南

暂未更新 · 2016-04-20

2012 JSDT指南：糖尿病患者血液透析

暂未更新 · 2012-03-19

2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）

暂未更新 · 2017-06-21

2017 KSN临床实践指南：中东呼吸综合征血液透析治疗

韩国肾脏病学会(KSN,Korean Society of Nephrology) · 2017-06-01

2017 ISRNM共识声明：血液透析治疗期间饮食

国际肾营养和代谢学会(ISRNM,International Society of Renal Nutrition and Metabolism) · 2017-12-20

2017年ISRNM《血液透析治疗期间饮食》专家共识解读

暂未更新 · 2018-07-20